WeedLife News Network

Last week, the cannabis sector rallied after Kamala Harris’ debate with Vice President Mike Pence. We believe the reason for the move higher is related to Harris stating that cannabis would be decriminalized under a Joe Biden administration.

In late 2019, Pew Research Center conducted a survey that found that two-thirds of Americans believe that cannabis should be legal. The survey also found that there has been a significant decline in the number of adults who believe that cannabis should be illegal. According to the survey, the percentage of adults who oppose the legalization of cannabis has fallen from 52% in 2010 to 32%.

Numbers do not lie, and the American people want cannabis to be legalized. The COVID pandemic put considerable pressure on the global economy and the US economy was not immune to this. States desperately need money and are looking for additional revenue streams in a post-pandemic world.

As it relates to economies (state and federal) finding new revenue streams, the legalization of sports betting was the first domino to fall. The change in regulation has been a catalyst for the US economy (and stock market) and several sports betting companies have recently gone public and are valued at more than $50 billion in aggregate (Draft Kings and Penn National Gaming).

We believe that the legalization of cannabis would prove to be an even larger taxable revenue stream than sports betting. States need more revenue and we expect cannabis to draw new voters to the polls and play an important role in the outcome of the November election.

Often triggered by stress, new studies are showing that psoriasis can be better managed by diet, oral health, and even CBD.

The National Psoriasis Foundation states that upwards of 8 million people have the auto-immune skin disorder. Often accompanied by arthritis, psoriasis not only causes scaling of the skin, but complications to fingernails as well. 

Affecting everyone from children to adults, psoriasis can lead to anxiety and depression, as individuals with the skin disorder are often afraid of being ridiculed. Usually treated with Humira and Enbrel, psoriasis comes with a shocking price tag and complications that are often difficult to ignore. 

A 2014 study published in the journal Drugs in Context found that Humira had a price tag upwards of $39,000, while Enbrel’s annual cost was around $46,000. Stelara, the most expensive drug, was found to cost over $53,000. As TNF blockers, while medications like Humira help against psoriasis, they can lower the body’s ability to fight infections and cause serious side effects. 

Even more interesting, a September 2019 study in London found that, “A number of medications commonly prescribed by rheumatologists may interact with cannabidiol oil” (CBD oil). The most affected medicines appear to be corticosteroids (including hydrocortisone and prednisolone) since CBD, “is a potent inhibitor of CYP3A.” Put plainly, CBD may block the effects of the other medicine. 

According to a Centers for Disease Control and Prevention survey of more than 5,400 people, almost 11% of United States adults reported seriously contemplating suicide in June.

The most stunning moments in my years of involvement in the marijuana legalization movement were when someone told me, “I haven’t tried to kill myself since I started using marijuana.” 

I am not a doctor, a psychologist, or even a counselor, so I was really unprepared for that. I have had cancer patients tell me that if they had not had a few tokes of marijuana to help them with the extreme nausea from chemotherapy, they would have chosen to die from the cancer rather than endure the hellish side effects from the chemo. The pharmaceutical antiemetics had stopped working.

Even in 1991, “More than 44% of the respondents report recommending the (illegal) use of marijuana for the control of emesis to at least one cancer chemotherapy patient. Almost one half (48%) would prescribe marijuana to some of their patients if it were legal. As a group, respondents considered smoked marijuana to be somewhat more effective than the legally available oral synthetic dronabinol ([THC] Marinol;” 

And I have known patients who did kill themselves rather than go to prison and be tortured to death by a regime that would watch them die in pain rather than allow them to use that plant. 

The two of you, plus others in your support network, are a team working to achieve one goal: your well-being.

The decades-long stigmatization of cannabis can make initiating conversations about its use awkward and difficult, particularly with your doctor. Add to that the knowledge — or even a hunch — your doctor may be skeptical about the benefits of cannabis, raising the topic can be downright intimidating. But it doesn’t have to be.

Your medical doctor is among the most educated and trained professionals you invite into your circle of trust. In addition to four years of undergraduate school, another four years in medical school and three to seven years of residency, being a doctor requires constant continuing education and recertification.

But throughout their education and training, your doctor was taught that natural remedies have limitations, and when the body can’t function on its own, it needs therapies beyond natural remedies to make you better. What’s more, the federal prohibition against cannabis — which has until recently included all forms of CBD — U.S. physicians have not been exposed to a lot of credible research and clinical trials.

In other words, if your doctor is a cannabis skeptic, it’s not entirely their fault. Years of training combined with the law of the land shaped those opinions. But it’s also important to remember that your physician is invested in your health. Long before he or she embarked on the long journey to become a doctor, they likely just wanted to help people. After they put in the long hours at school and hands-on training in residency, they swore an oath to help you. They want a good health outcome for you as much as you do. The two of you, plus others in your support network, are a team working to achieve one goal: your well-being.

CBD, one of the main components of the cannabis plant, is now being looked at as a highly effective remedy for all kinds of conditions.

Although not enough research has been conducted to prove it can cure any specific ailments, research indicates it can be effective in treating a wide variety of health issues.

When you read about all of its benefits, it almost seems like some kind of “miracle drug.”

Unfortunately, there is no such thing as a miracle drug.

Even though it is holistic and safe, CBD does have some side effects associated with its use. 

With just 21 days till voters in New Jersey get to decide on whether to legalize recreational marijuana in their state, a majority of them appear to be in favor of the measure, according to a new poll. 

Released last week by Fairleigh Dickinson University, the poll was conducted from September 30 through October 5 and included 582 randomly selected likely voters in the Garden State. Sixty-one percent of those surveyed said that they support legalization, while only 29% said they will vote against the measure.

Among Democrats, 71% of those contacted said they will vote yes on November 3. On the other hand, the percentage of Republicans that would support legalization was reported at 52%. 

New Jersey Governor Phil Murphy has made cannabis legalization a policy priority of his, but previous attempts to legalize cannabis via the state legislature have proven unsuccessful. Voters will instead decide on the matter on Election Day, when the country either re-elects President Donald Trump or chooses his opponent Joe Biden to lead the U.S for the next four years. 

Recently, Murphy released a pro-legalization video, in which the governor urged New Jersey voters to end prohibition, underscoring that it costs taxpayers $150 million every year. 

Many cannabis flowers are dried and cured before going to market, but live products are crafted using flower that is taken fresh off the plant. The flavor and aromatic notes are robust and more closely resemble that of the live cannabis plant than other concentrates. This may be why live resin products are in such high demand in all adult-use cannabis markets. Consumers don’t just dab live resin, they are also buying live vape cartridges. According to statistics from the BDSA Green Edge platform, live resin captures a 22% share of California’s vape market.

Headspace Technology

Research-focused terpene company Eybna Technologies noticed the market’s natural preference for live resin and sought to understand why these products were more desirable to the consumer. To do this, the terpene profile of a few cannabis plants were studied at three phases. The data was collected from the plant using the company’s proprietary Headspace technology which can provide insight into the chemical makeup of flowering plants. Headspace technology is a tool traditionally used in the fragrance industry to capture the makeup of plants at their aromatic peak. This is the first time the technology has been used for researching the cannabis plant.

All plants used in this study were grown in controlled conditions in a medical cannabis greenhouse. Researchers used Headspace tech to collect data from multiple top colas on the same plant to cut down the possibility for error. The study was focused on monitoring the patterns of terpene change throughout the cannabis life cycle in hopes of revealing the phytochemical difference between cured and live plant profiles.

The Headspace technology utilizes an adsorbent fiber located within a hollow glass dome to collect various volatile compounds from the live plant. Using this fiber, terpene content was collected at 3 stages: from fresh colas on the live plant, after they had been dried for one week, and again after being dried and cured.

The Results

As expected, the results offer insight into which terpenes degraded/evaporated and which preserved at various points of production from the farm to the dispensary shelf. Findings show that at the fresh, planted state, a cultivar has the highest expression of monoterpenes like Beta Myrcene, Alpha Pinene, Beta Pinene, and Limonene. After one week of drying and curing, each of these terpenes decreased significantly — Beta Myrcene content decreased by 55%. While monoterpenes were decreased during the curing process, sesquiterpenes like Alpha Humulene and Beta-Caryophyllene were increased. Sesquiterpenes almost doubled in their ratio from the total terpene content in data taken after the harvest processes were complete, with Alpha-Humulene increasing 100% and Germacrene increasing 154%.

Mila Jansen’s story is quite the odyssey. The renowned hash maker escaped from Holland’s Home for Unwed Mothers and opened both a clothing store “for the happy and free” and an underground tea house in Amsterdam before she invented the Pollinator and earned the title of Hash Queen. The Pollinator, the first mechanical tool to separate trichomes from plant matter, was unveiled at the 1994 High Times Cup in Amsterdam and represented a revolutionary moment in the ancient practice of hash making. 

New Jersey looks set to be the next state to legalize marijuana. It's on the ballot come Election Day on November 3, the polls are looking good, and while it's not the only state with marijuana legalization on the ballot, the others—Arizona, Montana, and South Dakota—are all out West, and the Garden State should beat them by a few hours.

The New Jersey legalization initiative, Public Question 1, would amend the state constitution to legalize the recreational use of marijuana and its cultivation, processing, and retail sale by a person who is at least 21 years old. It also designates the existing Cannabis Regulatory Commission (CRC), which currently handles medical marijuana, to regulate all legal marijuana commerce. Retail marijuana sales would be subject to the state sales tax of 6.625 percent, but any other state sales taxes would be prohibited. The initiative authorizes the legislature to let local governments add a 2 percent local sales tax.

It also leaves it up to the legislature and the CRC to address unresolved issues. Those include whether and how home cultivation would be allowed, how much weed people could possess, and detailed retail regulations.

If the measure passes, New Jersey will not only be the first to legalize marijuana this Election Day, it will also be the first mid-Atlantic state to do so, and the first to legalize it via a legislatively initiated voter referendum. Of the 11 states (and the District of Columbia) that have so far legalized marijuana, nine did it through citizen-based ballot initiatives, while in the other two, Illinois and Vermont, legislatures passed legalization bills.

Vermont has become the latest U.S. state to legalize cannabis sales after Governor Phil Scott allowed a new marijuana commercialization bill to take effect without his signature. 

In the run-up to his announcement, there was speculation the Vermont governor could even veto the bill, which passed the state legislature last month. Governor Scott was reluctant to sign the legislation over several concerns regarding driving under the influence of cannabis and vaping products, and what he feels as a lack of social equity provisions in the new bill.

With this move, Vermont became the 11th state to tax and regulate marijuana sales and the second to approve it via state legislature. 

“There is still more work to be done to ensure the health and safety of our kids and the safety of our roadways, we should heed the public health and safety lessons of tobacco and alcohol. Further, I believe we are at a pivotal moment in our nation’s history which requires us to address systemic racism in our governmental institutions. We must take additional steps to ensure equity is a foundational principle in a new market,” the governor wrote to lawmakers.

He added that the concerns of communities disproportionately targeted by the so-called War on Drugs were not adequately addressed in the legislation.

Issuing of the first commercial licence for growing industrial hemp in Australia’s Northern Territory was announced on Friday – and it’s been a long time coming.

The successful licensee is Michael Jakobi:

“I applied for a commercial hemp licence because I wanted an alternative to growing hay and because I thought it would be a good rotational fit with some of my crops,” said Mr. Jakobi. “The fact that hemp is multi-use is very appealing, I am also interested in the possible soil conditioning benefits planting hemp may have for my future crops.”

The Northern Territory Government seems pretty pumped about the prospects for local production of hemp.

“To grow our economy, we need to diversify our economy – and expanding into the exciting sector of industrial hemp does just that,” said Minister for Agribusiness and Aquaculture Nicole Manison. “Starting an industrial hemp industry here in the Territory brings with it new jobs and new manufacturing and exporting opportunities – the potential is very exciting.”

A cannabis product may fail contaminant testing if it has unsafe levels of microbials, heavy metals or pesticides.

While cannabis has many beneficial properties for both medical and recreational users, it also comes with intrinsic dangers like mold and yeast.

Growing cannabis sometimes involves pesticides, and the water can be polluted.

Most states where cannabis is legal have enacted legislation that requires companies to pass tests before releasing their product on the market. This, in turn, created a problem for companies that must ensure their product is safe and compliant with all regulations.

Luckily, the demand for a pure cannabis spurred the development of decontamination technology.

With recreational sales growing from $9.8 million in January to $65.5 million by August, there’s no questioning Michigan’s potential.

In December of 2019, Michigan became the tenth state in the U.S. to legalize adult-use cannabis. Less than a year in, it’s already outpaced Nevada to become the fifth highest-grossing state for cannabis sales and is on track to surpass $1 billion in sales, according to data from Headset.

In addition to its fast-growing new adult-use market, Michigan’s medical market is ranked #2 in the country, second only to California. Now, all eyes are on The Great Lake State as cannabis operators and investors across the U.S. seek to claim their share of this high-potential market.

Shares of cannabis producers soared on the stock market Thursday following the vice presidential debate, during which Kamala Harris announced the Biden administration would decriminalize marijuana at the federal level.

"We will decriminalize marijuana and we will expunge the records of those who have been convicted of marijuana," the California senator (D) said.

What Can Pot Stock Investors Look Forward to Next Year?

The record wildfires that have blanketed the West Coast in smoke and ash also have blocked out essential sunlight and set back the growth of outdoor marijuana plants by weeks, leaving growers with less-than-ideal options for when to harvest their plants.

Cannabis growers in California, Oregon and Washington state are contemplating two choices in the face of wildfires that have burned more than 5 million acres:

Michigan has taken an innovative approach to getting more entrepreneurs involved in the state’s marijuana industry—Microbusinesses, self-contained businesses that do not interact with the rest of the marijuana market. 

As it stands right now there are only two countries on earth that have passed an adult-use cannabis legalization measure.

The first to ever do it was Uruguay in 2013.

Uruguay’s legalization model is somewhat limited in that only residents can legally purchase adult-use cannabis.

Canada became the first G-7 nation to legalize cannabis for adult-use when it passed a nationwide legalization measure in 2018. 

The legalization model in Canada is such that any legally aged adult from anywhere on the planet can come to Canada and make a legal adult-use cannabis purchase.

Arkansas medical marijuana dispensaries are experiencing a shortage of the flower form of the product and a spokesman for Alcoholic Beverage Control said the agency is looking into the supply issue.

The number of medical marijuana patients in the state has surged past 80,000. The state has only four cultivators in operation, and dispensaries report having trouble getting some strains entirely. The supply of other products, such as tinctures, vape cartridges and edibles, is sufficient, dispensary owners say. 

“As of now, what we know is there have been shortages across the state of specific strains,” spokesman Scott Hardin said. “We have not seen any dispensaries that are totally out of product altogether. Typically, [the strain issues] have been resolved in a brief period of time.”

Fort Cannabis Co. in Fort Smith has run out of flower on a couple of occasions but the supply has generally been replenished within a day, according to Fort Cannabis General Manager Jordan Mooney. 

“It’s never too long, like days at a time, or anything like that,” Mooney said. Sales of flower, however, account for the majority of its business, Mooney said.